A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

NCT05265767 ·Status: COMPLETED ·Phase: PHASE1

Prophylaxis Regimen for Hemophilia A Patients

NCT05036278 ·Status: COMPLETED ·Phase: PHASE4

A Gene Therapy Study for Hemophilia B

NCT02484092 ·Status: COMPLETED ·Phase: PHASE2

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

NCT04418414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

NCT05709288 ·Status: RECRUITING ·Phase: PHASE1

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662 ·Status: COMPLETED ·Phase: PHASE3

A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT05265286 ·Status: COMPLETED ·Phase: PHASE2

Hemophilia B Gene Therapy With AAV8 Vector

NCT01620801 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

NCT05203679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

NCT05027230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5

NCT03520712 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

NCT04370054 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

NCT05619926 ·Status: COMPLETED ·Phase: PHASE2

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

NCT04456387 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

NCT06111638 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

NCT06289166 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

NCT05360706 ·Status: ACTIVE_NOT_RECRUITING

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

NCT07080905 ·Status: RECRUITING ·Phase: PHASE3

A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

NCT04747964 ·Status: COMPLETED ·Phase: PHASE1

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

NCT06922045 ·Status: RECRUITING ·Phase: PHASE3

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

NCT00076557 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

NCT02576795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)

NCT05082116 ·Status: COMPLETED ·Phase: PHASE3